pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked · 368 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
  • Marketed
    (brimonidine tartrate + timolol maleate)
    Brimonidine Tartrate + Timolol Maleate ((brimonidine tartrate + timolol maleate))
    Glaucoma Sentiss Pharmaceuticals LLC
  • Marketed
    (cyclopentolate hydrochloride + phenylephrine hydrochloride)
    Cyclomydril ((cyclopentolate hydrochloride + phenylephrine hydrochloride))
    Mydriasis$ALC ALCON INC
  • Marketed
    (dexamethasone + tobramycin)
    Tobradex ST ((dexamethasone + tobramycin))
    Ocular Inflammation$HROW HARROW, INC.
← prev
page 3 of 13
next →
131
Pain89
Neurology1
  • Marketed
    (dextromethorphan + promethazine)
    Promethazine DM ((dextromethorphan [INN] + promethazine [INN]))
    Nasopharyngitis (Common Cold) PAI Holding Co LLC
  • Phase 2
    (difluprednate + povidone iodine)
    (difluprednate + povidone iodine [USP])
    Viral Conjunctivitis iView Therapeutics Inc
  • Marketed
    (gramicidin + neomycin sulfate + polymyxin B)
    Neomycin + Polymyxin B Sulfates + Gramicidin ((gramicidin [INN] + neomycin sulfate + polymyxin B [INN]))
    Bacterial Conjunctivitis Sciegen Pharmaceuticals Inc
  • Marketed
    (hydrocortisone + neomycin sulfate + polymyxin B)
    Casporyn HC ((hydrocortisone [INN] + neomycin sulfate + polymyxin B [INN]))
    Otitis Externa Casper Pharma LLC
  • Marketed
    (ketorolac tromethamine + phenylephrine hydrochloride)
    Ketorolac Tromethamine + Phenylephrine Hydrochloride ((ketorolac tromethamine + phenylephrine hydrochloride))
    Ocular Pain (Eye Pain) Lupin Ltd
  • Marketed
    (latanoprost + netarsudil mesylate)
    Rocklatan ((latanoprost + netarsudil mesylate))
    Ocular Hypertension$ALC ALCON INC
  • Marketed
    (naphazoline + pheniramine maleate)
    Naphazoline Hydrochloride + Pheniramine Maleate ((naphazoline [INN] + pheniramine maleate))
    Allergic Conjunctivitis Altaire Pharmaceuticals Inc
  • Phase 3
    (neltependocel + Y-27632)
    Vyznova (neltependocel [INN])
    Corneal Edema Aurion Biotech Inc
  • Marketed
    (polymyxin B + trimethoprim sulfate)
    Polymyxin B + Trimethoprim Sulfate Pacific ((polymyxin B [INN] + trimethoprim sulfate))
    Bacterial Conjunctivitis Pacific Pharmaceuticals USA
  • Marketed
    (prednisolone sodium phosphate + sulfacetamide sodium)
    Sulfacetamide Sodium + Prednisolone Sodium Phosphate ((prednisolone sodium phosphate + sulfacetamide sodium))
    Anterior Uveitis Bausch Health US LLC
  • Phase 3
    (riboflavin + sodium iodide)
    (riboflavin [INN] + sodium iodide [USP])
    Keratoconus Epion Therapeutics Inc
  • Preclinical
    (rifampin + polymyxin B + trimethoprim)
    (rifampin + polymyxin B [INN] + trimethoprim)
    Bacterial Keratitis University of Rochester
  • Phase 3
    4D-150
    Wet (Neovascular / Exudative) Macular Degeneration$FDMT 4D Molecular Therapeutics, Inc.
  • Preclinical
    6SP-2407
    Macular Degeneration 6S Pharma LLC
  • Phase 2
    A-197
    Keratoconjunctivitis Sicca (Dry Eye) Aramis Biosciences Inc
  • Preclinical
    AAV-RDH12
    no indication$MGTX MeiraGTx Holdings plc
  • Phase 2
    AAVB-039
    Juvenile Macular Degeneration (Stargardt Disease) AAVantgarde Bio Srl
  • Phase 2
    ABI-110
    Polypoidal Choroidal Vasculopathy Avirmax Inc
  • Preclinical
    ABO-503
    Retinal Degeneration$ABEO ABEONA THERAPEUTICS INC.
  • Preclinical
    ABO-504
    Juvenile Macular Degeneration (Stargardt Disease)$ABEO ABEONA THERAPEUTICS INC.
  • Preclinical
    ABO-505
    Optic Neuropathy$ABEO ABEONA THERAPEUTICS INC.
  • Phase 2
    ACDN-01
    Juvenile Macular Degeneration (Stargardt Disease) Ascidian Therapeutics Inc
  • Preclinical
    AChE Inhibitors
    Acne Vulgaris Attillaps Holdings Inc
  • Preclinical
    AG-73305
    Retinal Vein Occlusion Allgenesis Biotherapeutics Inc
  • Preclinical
    AGN-001
    Retinitis Pigmentosa (Retinitis) Agnos Therapeutics Inc
  • Preclinical
    AMP-107
    Diabetic Macular Edema$AMPH Amphastar Pharmaceuticals, Inc.
  • Phase 2
    ANXV
    Retinal Vein Occlusion Annexin Pharmaceuticals AB